Exploring Natural Products to Control Type 2 Diabetes Mellitus through Targeting Advanced Glycation End Products
Journal Title: Iranian journal of diabetes and obesity (IJDO) - Year 2024, Vol 16, Issue 3
Abstract
Cardiovascular disease (CVD) and diabetes mellitus (DM) are the pressing global health issue, with advanced glycation end products (AGEs) playing a crucial role in its development. AGEs are harmful compounds formed through chronic exposure to elevated blood glucose levels and oxidative stress, both of which are prevalent in diabetes mellitus. These molecules have detrimental effects on vascular function, inflammation, and oxidative stress, exacerbating CVD progression. Conventional strategies for managing AGEs are often limited by side effects and insufficient efficacy, driving the need for alternative approaches. This review investigates the intricate relationship between AGEs, diabetes mellitus, and CVD, with a focus on the therapeutic potential of natural products-particularly phenolic compounds. The review explores how AGEs contribute to the pathogenesis of diabetes-related complications and their impact on cardiovascular health. It examines the molecular mechanisms underlying AGE formation and the inhibitory effects of various natural compounds on this process. Additionally, the review assesses preclinical and clinical evidence supporting the efficacy of these natural agents in mitigating AGE-induced damage. By highlighting the significant role of AGEs in diabetes and CVD, the study underscores the potential of natural products to counteract AGE accumulation. It provides an in-depth analysis of AGE biochemistry, their sources, and the effects of different natural products on AGE formation. The review concludes by emphasizing the promise of natural compounds in reducing oxidative stress and inflammation, and thereby lowering the risk of cardiovascular complications associated with diabetes. This comprehensive overview advocates for the integration of natural products into therapeutic strategies for managing AGE-mediated cardiovascular and diabetic conditions.
Authors and Affiliations
Pradeep Kumar Dabla,Dharmsheel Shrivastav,Mirza Masroor Ali Beg,Qing Meng,
Keywords
Related Articles
- EP ID EP743452
- DOI -
- Views 24
- Downloads 0
Orchestrating Metabolic Homeostasis: The Role of Gut Hormones in Next-Generation Therapies for Metabolic Syndrome
Metabolic disorders, including obesity and type 2 diabetes, have reached epidemic proportions globally, necessitating novel therapeutic approaches. The gut-brain axis, particularly gut hormones, plays a crucial role in m...
The impact of Polymorphisms of rs689 and rs757110 in Familial Type 2 Diabetes: A Case-Control Study in the Iranian Population
Objective: Understanding the genetic basis of type 2 diabetes mellitus (T2DM) is essential in getting its etiology and designing effective preventive strategies. Evaluation of the association between the gene polymorphis...
The Effectiveness of Acceptance and Commitment Therapy on Resilience at Women with Type 2 Diabetes in Yazd City
Objective: Introduction: Diabetes is a chronic disease that engages affected person for long time and endangers mental health of affected persons. Purpose of this paper is examining the effect of training courses of acce...
Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
Objective: The objective of the present analysis was to compare the effect of these two treatment regimens (Novomix insulin twice or thrice-daily versus once-daily insulin glargine plus twice or thrice-daily insulin aspa...
Vildagliptin-Associated Bullous Pemphigoid: A Case Report
Objective: Bullous pemphigoid is a rare autoimmune skin disorder characterized by blistering, urticarial lesions, which are sometimes associated with adverse drug reactions. Vildagliptin is an oral anti-diabetic agent th...